Trial Profile
A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Amifostine (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 25 Jun 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 22 Apr 2010 New trial record